Peter C. Farrell

Filings by Peter C. Farrell span 3 companies, the busiest being ResMed Inc, Evolus, Inc. and Arcturus Therapeutics Holdings Inc. The record holds 41 filings, for trades running from 4 January 2016 to 2 September 2026.

The open-market side counts 1 purchase for €92k alongside 22 sales for €13.2M. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 12 share grants and 4 option exercises. Since January 2026: no purchases and 6 sales on the market.

Most recently, on 4 September 2026, the filings show an open-market sale worth €197k in ResMed Inc. The last purchase on record was published on 6 September 2022, which is 1,503 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.